Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Eylea, aflibercept ophthalmic solution (VEGF Trap-Eye)
print preview
bookmark
share with colleague
General Information
Company
Regeneron Pharmaceuticals Inc.
Description
Human fusion protein that binds all forms of VEGF-A and placental growth factor (PIGF)
Molecular Target
Vascular endothelial growth factor A (VEGF-A)
;
Placental growth factor (PGF) (PlGF)
Mechanism of Action
Vascular endothelial growth factor A (VEGF-A) inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy